Keaveny, Nahum Mndez-Snchez Expert Review of Gastroenterology & Hepatology .2025
Tirzepatide is unique because it acts as a dual agonist for two important gut hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
FAQs About GLP-1 and GIP/GLP-1s for Obesity 9 Although GLP-1 medications have been used for type 2 diabetes since 2005 (in lower doses than what is prescribed now for weight loss), its still too early to know the long-term effects of using them specifically for obesity
The evaluation involved interviewing participants concerning their developmental history, present illness, life history, and family history
They should have specific training or experience with peptide therapy and growth hormone optimization
They highlight the fact that they offer the same price for every dose (which is rare), have flat monthly costs, no shipping fees, and provide all-inclusive care